Companies / Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc.
Nasdaq: SNOACIK 1367083BOULDER, CO
Financials · FY2026
Ownership
4.8M shares outstanding · as of Aug 6, 2026
Ownership
| Institutions | 2.36% | 112,947 |
| Public float | 97.64% | 4,675,478 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Birnbaum Jay EDirector | — | — |
Dal Poggetto JohnController | — | — |
Dvonch Jerome JChief Financial Officer | — | — |
Jacoby VanessaDirector | — | — |
McLaughlin JohnDirector | — | — |
Trombly Amy MossCEOChief Executive Officer | — | — |
Weigerstorfer PhilippeDirector | — | — |
Institutional holders 16
View all →| Holder | Value | % of shares |
|---|---|---|
| $222.0K | 1.27% | |
| $68.7K | 0.39% | |
| $42.5K | 0.42% | |
| $40.7K | 0.23% | |
| $2.8K | 0.02% | |
| $1.8K | 0.01% | |
| $1.4K | <0.01% | |
| $440 | <0.01% | |
| $139 | <0.01% | |
| $91 | <0.01% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $8.6K | +4K +25.35% | 19,941 0.42% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $4 | +1 +5.88% | 18 <0.01% of shares | low |
| Q3 2024 as of | Danske Bank A/S 13F manager | New | Common Stock | $3 | +1 | 1 <0.01% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SNOA | Common Stock | 83558L303 |